Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TVP23C pseudogene 2 is classified as a pseudogene, which means it is a DNA sequence similar to a functional gene (TVP23C, trans-Golgi network vesicle protein 23 homolog C), but it does not encode a functional protein and lacks biological activity as a target[3][7]. Pseudogenes are typically regarded as non-coding sequences and do not serve as molecular targets for drugs or therapeutic interventions. TVP23CP2 is annotated in genomic resources, but there is no evidence of it being involved in molecular pathways, disease mechanisms, or therapeutic modulation. For structured information extraction, TVP23CP2 should be excluded from lists of conventional targets. If you were seeking drug targets, TVP23C (trans-Golgi network vesicle protein 23 homolog C) is the protein-coding paralog, involved in protein secretion and vesicle-mediated transport, and has potential roles in certain diseases such as podoconiosis and elephantiasis[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TVP23C pseudogene 2 (TVP23CP2).